Application of chitosan microspheres for nasal delivery of vaccines
Authors:
- 1 November 2009
- journal article
- review article
- Published by Elsevier in Biotechnology Advances
- Vol. 27 (6) , 857-865
Abstract
No abstract availableKeywords
This publication has 86 references indexed in Scilit:
- Chitosan microspheres as candidate plasmid vaccine carrier for oral immunisation of Japanese flounder (Paralichthys olivaceus)Veterinary Immunology and Immunopathology, 2008
- Pluronic® F127 enhances the effect as an adjuvant of chitosan microspheres in the intranasal delivery of Bordetella bronchiseptica antigens containing dermonecrotoxinVaccine, 2007
- Gene Transfer by DNA/mannosylated Chitosan Complexes into Mouse Peritoneal MacrophagesBiotechnology Letters, 2006
- Nasal administration of Carbamazepine using chitosan microspheres: In vitro/in vivo studiesInternational Journal of Pharmaceutics, 2006
- Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA deliveryAdvanced Drug Delivery Reviews, 2005
- Enhancement of immune responses by DNA vaccination through targeted gene delivery using mannosylated cationic liposome formulations following intravenous administration in miceBiochemical and Biophysical Research Communications, 2004
- Ultrastructural study on the follicle‐associated epithelium of nasal‐associated lymphoid tissue in specific pathogen‐free (SPF) and conventional environment‐adapted (SPF‐CV) ratsJournal of Anatomy, 2000
- The role of nasopharyngeal lymphoid tissueImmunology Today, 1992
- An aminoboronic acid derivative inhibits thymopentin metabolism by mucosal membrane aminopeptidasesLife Sciences, 1990
- Intranasal Administration of Peptides: Nasal Deposition, Biological Response, and Absorption of DesmopressinJournal of Pharmaceutical Sciences, 1986